Get the Stockscreener App
18.49
0.87%
0.16
Si Bone Inc stock is traded at $18.49, with a volume of 840.31K.
It is up +0.87% in the last 24 hours and up +32.83% over the past month.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
See More
Previous Close:
$18.33
Open:
$18.26
24h Volume:
840.31K
Relative Volume:
2.00
Market Cap:
$594.98M
Revenue:
$150.71M
Net Income/Loss:
$-40.85M
P/E Ratio:
-18.31
EPS:
-1.01
Net Cash Flow:
$-25.98M
1W Performance:
+32.17%
1M Performance:
+32.83%
6M Performance:
+20.69%
1Y Performance:
+18.98%
1-Day Range:
$17.74
$18.62
1-Week Range:
$13.64
$18.91
52-Week Range:
$11.70
$19.16
Si Bone Inc Stock (SIBN) Company Profile
Name
Si Bone Inc
Sector
Industry
Phone
(408) 207-0700
Address
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
18.49 | 594.98M | 150.71M | -40.85M | -25.98M | -1.01 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-24 | Reiterated | Needham | Buy |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-07-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-08-21 | Initiated | Citigroup | Buy |
| Mar-09-21 | Reiterated | Needham | Buy |
| Dec-16-20 | Reiterated | Needham | Buy |
| Aug-04-20 | Reiterated | Needham | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-05-20 | Reiterated | Needham | Buy |
| Feb-19-20 | Initiated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-18-19 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-12-18 | Initiated | BofA/Merrill | Buy |
| Nov-12-18 | Initiated | Canaccord Genuity | Buy |
| Nov-12-18 | Initiated | JMP Securities | Mkt Outperform |
| Nov-12-18 | Initiated | Morgan Stanley | Overweight |
View All
Si Bone Inc Stock (SIBN) Latest News
Insider Sell: Anshul Maheshwari Sells 33,287 Shares of SI-BONE I - GuruFocus
Trading Day Review: SI-BONE Inc (SIBN) Gains Momentum, Closing at 18.33 - DWinneX
Earnings Update: SI-BONE, Inc. (NASDAQ:SIBN) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts - simplywall.st
SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025 - marketscreener.com
Wall Street Analysts Think Si-Bone (SIBN) Could Surge 41.21%: Read This Before Placing a Bet - Yahoo Finance
Revenues Tell The Story For SI-BONE, Inc. (NASDAQ:SIBN) As Its Stock Soars 30% - simplywall.st
SI-BONE, Inc. (NASDAQ:SIBN) Q1 2025 Earnings Call Transcript - Insider Monkey
The 15% return this week takes SI-BONE's (NASDAQ:SIBN) shareholders three-year gains to 25% - simplywall.st
SI-BONE First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
MetLife Investment Management LLC Boosts Holdings in SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
SI-BONE (SIBN) Receives Reiterated Overweight Rating from Cantor Fitzgerald | SIBN Stock News - GuruFocus
SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025 | SIBN Stock News - GuruFocus
SI-Bone (SIBN) Target Price Lifted by Truist Following Strong Q1 Performance | SIBN Stock News - GuruFocus
Medical Device Leader SI-BONE to Share Growth Strategy at Major BofA Healthcare Conference - Stock Titan
SI-BONE (SIBN) Receives Price Target Increase from Truist Securities | SIBN Stock News - GuruFocus
SI-BONE (SIBN): Analyst Reiterates Buy Rating and Target Price | - GuruFocus
Cantor Fitzgerald maintains SI-BONE stock with $25 target - Investing.com
Cantor Fitzgerald maintains SI-BONE stock with $25 target By Investing.com - Investing.com India
JMP maintains SI-BONE stock with $32 target post-earnings By Investing.com - Investing.com Nigeria
JMP maintains SI-BONE stock with $32 target post-earnings - Investing.com
Forecasting The Future: 6 Analyst Projections For SI-BONE - Benzinga
SI-Bone price target raised to $22 from $20 at Truist - TipRanks
SI-BONE Inc (SIBN) Q1 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Needham maintains Buy rating and $24 target on SI-BONE stock - Investing.com India
SI-BONE revenue up 24.9% to USD 47.3M in Q1 2025 - Medical Buyer
SI-BONE Inc (SIBN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Positive ... - Yahoo Finance
SI-BONE, Inc. Reports Strong Q1 2025 Growth - TipRanks
Si-Bone Q1 2025 slides: revenue jumps 25%, achieves positive EBITDA - Investing.com
SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025 - The Globe and Mail
SI-BONE Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Si-Bone’s Q1 2025 results beat expectations, stock surges - Investing.com
SI-BONE Inc reports results for the quarter ended March 31Earnings Summary - TradingView
SI-BONE (SIBN) Projects 16-18% Revenue Growth and Strong 2025 Fi - GuruFocus
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Si-Bone: Q1 Earnings Snapshot - Midland Daily News
SI-BONE Inc. Q1 Loss Decreases, Beats Estimates - Nasdaq
SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance | SIBN Stock News - GuruFocus
SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance - marketscreener.com
Invesco Ltd. Increases Stock Holdings in SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
Long Term Trading Analysis for (SIBN) - news.stocktradersdaily.com
Barclays PLC Has $1.39 Million Stock Position in SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
SI-BONE Inc (SIBN) Q1 2025: Everything You Need to Know Ahead of Earnings - Yahoo Finance
SI-BONE, Inc. (NASDAQ:SIBN) Stake Lessened by Legal & General Group Plc - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
SEC Form DEFA14A filed by SI-BONE Inc. - Quantisnow
SI-BONE, Inc. (NASDAQ:SIBN) Shares Sold by Russell Investments Group Ltd. - Defense World
Geode Capital Management LLC Raises Stock Holdings in SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
JPMorgan Chase & Co. Acquires 102,660 Shares of SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
Arthralgia Treatment Market Size in 7MM is expected to grow at - openPR.com
SI-BONE, Inc. (NASDAQ:SIBN) Shares Acquired by Alliancebernstein L.P. - Defense World
Why SI-BONE Inc (NASDAQ: SIBN) Is A Great Stock Pick For Momentum Investors - Stocksregister
Si Bone Inc Stock (SIBN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):